Company Profile
Windtree Therapeutics Stock Price, News & Catalysts
- Ticker:
- WINT
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Stock performance
0.00 USD (0.00%)
Close
Last updated: August 24, 2026
—
Market cap
Why the stock is moving
As of Aug 24, 2026, WINT was little changed and closed at $0.0001. No new same-company headline was identified in the current news window.
Company overview
Business overview
Windtree Therapeutics is a specialty pharmaceutical company focused on respiratory and acute-care therapies, with a history of working on surfactant-based and other hospital-oriented programs. Its business has often been shaped by a narrow pipeline and strategic repositioning.
Geographic Base and Sector Classification
Windtree is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and respiratory therapeutics.
Business Model Characteristics
The company depends on clinical progress, corporate strategy, and financing to keep a limited set of programs moving. Investors watch updates on pipeline direction and the company's ability to preserve value in a difficult market.
Position Within the Biotechnology Landscape
Windtree occupies a small respiratory-specialty niche within biotech-adjacent pharma. The stock is usually driven by whether the company can create a clear, fundable development thesis.
Future catalysts
- Windtree’s catalysts are respiratory and critical-care product updates, plus any strategic or financing step that supports the company’s next phase. The stock remains sensitive to execution and capital.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Windtree Therapeutics (WINT)?
Windtree Therapeutics (WINT) most recently closed at 0.00 USD, a 0.00% move versus the previous session.
What does Windtree Therapeutics do?
Windtree Therapeutics is a specialty pharmaceutical company focused on respiratory and acute-care therapies, with a history of working on surfactant-based and other hospital-oriented programs. Its business has often been shaped by a narrow pipeline and strategic repositioning.
On which exchange is WINT stock listed?
Windtree Therapeutics (WINT) is associated with NASDAQ, United States, MedTech.
What is Windtree?
Windtree’s catalysts are respiratory and critical-care product updates, plus any strategic or financing step that supports the company’s next phase.
Which conditions is Windtree Therapeutics targeting with Windtree?
Windtree Therapeutics is associated with respiratory disease based on its company overview and current catalyst commentary.
How does Windtree Therapeutics describe recent progress with Windtree?
Windtree’s catalysts are respiratory and critical-care product updates, plus any strategic or financing step that supports the company’s next phase.
What is Therapeutics?
Windtree Therapeutics is a specialty pharmaceutical company focused on respiratory and acute-care therapies, with a history of working on surfactant-based and other hospital-oriented programs.
What should investors watch for with Therapeutics?
Windtree’s catalysts are respiratory and critical-care product updates, plus any strategic or financing step that supports the company’s next phase. The stock remains sensitive to execution and capital.